NCT00187941View on ClinicalTrials.gov

MPA PK Monitoring Strategy With MMF/FK Based Immunosuppression

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

August 31, 2005

Primary Completion Date

November 30, 2006

Study Completion Date

November 30, 2006

Conditions
Transplantation, RenalImmunosuppression
Interventions
DRUG

Mycophenolate Mofetil

Targeted MPA exposure to 30-60 mg/L/h during the first month post-transplant.

Trial Locations (1)

32610

University of Florida, Gainesville

All Listed Sponsors
collaborator

Hoffmann-La Roche

INDUSTRY

lead

University of Florida

OTHER

NCT00187941 - MPA PK Monitoring Strategy With MMF/FK Based Immunosuppression | Biotech Hunter | Biotech Hunter